Story · Medicine & Biotech

Effect of starting metformin on severe and long COVID-19 among people living with type 2 diabetes in England: a new user cohort study in OpenSAFELY-TPP

1 outlet · first reported by medRxiv (all subjects) 3d ago

Coverage, in order

  1. 3d ago
    medRxiv (all subjects) obscure study randomized trialn=19
    Effect of starting metformin on severe and long COVID-19 among people living with type 2 diabetes in England: a new user cohort study in OpenSAFELY-TPP

    Introduction: Observational studies report lower COVID-19 mortality among metformin users, but most used prevalent-user designs comparing long-term survivors with heterogeneous controls. Randomised trials suggest little or no mortality effect. No large observational study has used a new-user design…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.